Scientists retrospectively analyzed the association of clinical characteristics, comorbidities, and organ function with outcomes after conditioning with BCNU/carmustine, etoposide, cytarabine, and melphalan (BEAM) or thiotepa (TEAM).
[European Journal Of Haematology]